Literature DB >> 25062464

Impact of duration of critical illness on the adrenal glands of human intensive care patients.

Eva Boonen1, Lies Langouche, Thomas Janssens, Philippe Meersseman, Hilke Vervenne, Emilie De Samblanx, Zoë Pironet, Lisa Van Dyck, Sarah Vander Perre, Inge Derese, Greet Van den Berghe.   

Abstract

CONTEXT: Adrenal insufficiency is considered to be prevalent during critical illness, although the pathophysiology, diagnostic criteria, and optimal therapeutic strategy remain controversial. During critical illness, reduced cortisol breakdown contributes substantially to elevated plasma cortisol and low plasma ACTH concentrations.
OBJECTIVE: Because ACTH has a trophic impact on the adrenal cortex, we hypothesized that with a longer duration of critical illness, subnormal ACTH adrenocortical stimulation predisposes to adrenal insufficiency. DESIGN, SETTING AND PARTICIPANTS: Adrenal glands were harvested 24 hours or sooner after death from 13 long intensive care unit (ICU)-stay patients, 27 short ICU-stay patients, and 13 controls. Prior glucocorticoid treatment was excluded. MAIN OUTCOME AND MEASURE(S): Microscopic adrenocortical zonational structure was evaluated by hematoxylin and eosin staining. The amount of adrenal cholesterol esters was determined by Oil-Red-O staining, and mRNA expression of ACTH-regulated steroidogenic enzymes was quantified.
RESULTS: The adrenocortical zonational structure was disturbed in patients as compared with controls (P < .0001), with indistinguishable adrenocortical zones present only in long ICU-stay patients (P = .003 vs. controls). Adrenal glands from long ICU-stay patients, but not those of short ICU-stay patients, contained 21% less protein (P = .03) and 9% more fluid (P = .01) than those from controls, whereas they tended to weigh less for comparable adrenal surface area. There was 78% less Oil-Red-O staining in long ICU-stay patients than in controls and in short-stay patients (P = .03), the latter similar to controls (P = .31). The mRNA expression of melanocortin 2 receptor, scavenger-receptor class B, member 1, 3-hydroxy-3-methylglutaryl-CoA reductase, steroidogenic acute regulatory protein, and cytochrome P450 cholesterol side-chain cleavage enzyme was at least 58% lower in long ICU-stay patients than in controls (all P ≤ .03) and of melanocortin 2 receptor, scavenger-receptor class B, member 1, steroidogenic acute regulatory protein, and cytochrome P450 cholesterol side-chain cleavage enzyme at least 53% lower than in short ICU-stay patients (all P ≤ .04), whereas gene expression in short ICU-stay patients was similar to controls. CONCLUSION AND RELEVANCE: Lipid depletion and reduced ACTH-regulated gene expression in prolonged critical illness suggest that sustained lack of ACTH may contribute to the risk of adrenal insufficiency in long-stay ICU patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25062464     DOI: 10.1210/jc.2014-2429

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  Understanding the HPA response to critical illness: novel insights with clinical implications.

Authors:  Eva Boonen; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2014-11-19       Impact factor: 17.440

Review 2.  Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM).

Authors:  Djillali Annane; Stephen M Pastores; Wiebke Arlt; Robert A Balk; Albertus Beishuizen; Josef Briegel; Joseph Carcillo; Mirjam Christ-Crain; Mark S Cooper; Paul E Marik; Gianfranco Umberto Meduri; Keith M Olsen; Bram Rochwerg; Sophia C Rodgers; James A Russell; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2017-09-21       Impact factor: 17.440

3.  Hydrocortisone Therapy in Catecholamine-Resistant Pediatric Septic Shock: A Pragmatic Analysis of Clinician Practice and Association With Outcomes.

Authors:  Blake Nichols; Sherri Kubis; Jennifer Hewlett; Nadir Yehya; Vijay Srinivasan
Journal:  Pediatr Crit Care Med       Date:  2017-09       Impact factor: 3.624

Review 4.  Critical Illness-induced Corticosteroid Insufficiency: What It Is Not and What It Could Be.

Authors:  Arno Téblick; Jan Gunst; Greet Van den Berghe
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

Review 5.  Adrenal function and dysfunction in critically ill patients.

Authors:  Arno Téblick; Bram Peeters; Lies Langouche; Greet Van den Berghe
Journal:  Nat Rev Endocrinol       Date:  2019-07       Impact factor: 43.330

6.  Adrenocortical function during prolonged critical illness and beyond: a prospective observational study.

Authors:  Bram Peeters; Philippe Meersseman; Sarah Vander Perre; Pieter J Wouters; Dimitri Vanmarcke; Yves Debaveye; Jaak Billen; Pieter Vermeersch; Lies Langouche; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2018-09-13       Impact factor: 17.440

7.  Cortisol and adrenal androgens as independent predictors of mortality in septic patients.

Authors:  Rocío De Castro; David Ruiz; Bernardo-Alio Lavín; Jose Ángel Lamsfus; Luis Vázquez; Coral Montalban; Gilberto Marcano; Raquel Sarabia; María Paz-Zulueta; Cristina Blanco; Miguel Santibáñez
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

8.  Transcriptional Analysis of Sepsis-Induced Activation and Damage of the Adrenal Endothelial Microvascular Cells.

Authors:  Lan-Sun Chen; Sumeet P Singh; Gregor Müller; Stefan R Bornstein; Waldemar Kanczkowski
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-22       Impact factor: 5.555

Review 9.  Glucocorticoids and the Brain after Critical Illness.

Authors:  Alice R Hill; Joanna L Spencer-Segal
Journal:  Endocrinology       Date:  2021-03-01       Impact factor: 4.736

10.  ACTH and cortisol responses to CRH in acute, subacute, and prolonged critical illness: a randomized, double-blind, placebo-controlled, crossover cohort study.

Authors:  Bram Peeters; Philippe Meersseman; Sarah Vander Perre; Pieter J Wouters; Yves Debaveye; Lies Langouche; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2018-10-29       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.